UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

HPV-Based Screen-and-Treat Demonstration Project in Lilongwe

Not Applicable

Active, not recruiting

Conditions: Cervical Cancer
HIV Infections
HPV Infection

Interventions: Procedure: VIA and thermocoagulation

First Posted Date: 2019-09-17

Last Posted Date: 2024-10-22

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 1250

Registration Number: NCT04092257

Locations: 🇲🇼
University of North Carolina (UNC) Project-Malawi, Lilongwe, Malawi

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

Not Applicable

Completed

Conditions: Pulmonary Nodule, Multiple
Pulmonary Nodule, Solitary

Interventions: Device: Scatter corrected s-DCT

First Posted Date: 2019-09-03

Last Posted Date: 2022-08-08

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 38

Registration Number: NCT04076696

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer

Phase 2

Completed

Conditions: Cognitive Decline
Chemo-brain

Interventions: Drug: Memantine

First Posted Date: 2019-07-26

Last Posted Date: 2023-04-20

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 55

Registration Number: NCT04033419

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

High Intensity Interval Training in Endometrial Cancer

Not Applicable

Active, not recruiting

Conditions: Endometrial Cancer

Interventions: Behavioral: HIIT exercise

First Posted Date: 2019-07-18

Last Posted Date: 2024-03-25

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 32

Registration Number: NCT04025229

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

Phase 2

Completed

Conditions: Kidney Cancer

Interventions: Drug: Perflutren lipid microsphere
Drug: Sulfur hexafluoride lipid microspheres

First Posted Date: 2019-07-16

Last Posted Date: 2023-11-13

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 25

Registration Number: NCT04021238

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Phase 2

Active, not recruiting

Conditions: Bladder Cancer

Interventions: Drug: Pembrolizumab
Drug: Entinostat

First Posted Date: 2019-06-07

Last Posted Date: 2024-02-05

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT03978624

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

Not Applicable

Completed

Conditions: Oncology

Interventions: Other: Results of the brief geriatric assessment
Other: No results of brief geriatric assessments

First Posted Date: 2019-05-15

Last Posted Date: 2019-05-15

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 148

Registration Number: NCT03951090

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Compassionate Use Re-Infusion of ATLCAR.CD30

Conditions: Hodgkin Lymphoma, Adult

First Posted Date: 2019-04-16

Last Posted Date: 2021-12-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Registration Number: NCT03914885

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, North Carolina, United States

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

Phase 2

Completed

Conditions: Von-Hippel Lindau
Kidney Disease, Chronic

Interventions: Drug: Perflutren lipid microsphere
Drug: Sulfur hexafluoride lipid microspheres

First Posted Date: 2019-04-09

Last Posted Date: 2024-05-21

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT03907657

Locations: 🇺🇸
University of North Carolina of Chapel hill, Chapel Hill, North Carolina, United States

Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer

Not Applicable

Completed

Conditions: Invasive Bladder Cancer

Interventions: Other: Mobile Health app tool - Twistle

First Posted Date: 2019-03-05

Last Posted Date: 2020-06-12

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 33

Registration Number: NCT03862105

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy